As a critical catalytic subunit of system xCT, solute carrier family 7 member 11 (SLC7A11) expression level exhibits an upward trend in multiple cancer types and is an indicator of antiporter xCT activity [17]. This evidence concerns the gene SLC7A11 and cancer.